Home » Data Shows Combo Stent May Offer Advantages to Current Technologies
Data Shows Combo Stent May Offer Advantages to Current Technologies
OrbusNeich announced that pre-clinical data involving porcine coronary models demonstrate that the company’s Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher sirolimus eluting stent and the XIENCE V everolimus eluting stent.
redOrbit
redOrbit
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May